Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Paraplatin 150mg/15ml solution for infusion vials
0801050F0BBAEAE
|
Paraplatin | Carboplatin | Malignant Disease and Immunosuppression | No data available |
|
Paraplatin 450mg/45ml solution for infusion vials
0801050F0BBAFAF
|
Paraplatin | Carboplatin | Malignant Disease and Immunosuppression | No data available |
|
Paraplatin 50mg/5ml solution for infusion vials
0801050F0BBADAD
|
Paraplatin | Carboplatin | Malignant Disease and Immunosuppression | No data available |
|
Paraplatin 600mg/60ml solution for infusion vials
0801050F0BBAGAG
|
Paraplatin | Carboplatin | Malignant Disease and Immunosuppression | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.